Skip to main content
. 2023 Feb 27;12(5):e026696. doi: 10.1161/JAHA.122.026696

Table 1.

Demographic and Clinical Characteristics by Duration of Any Breastfeeding for the Index Pregnancy

Characteristics Never (n=509) <1 mo (n=317) 1 to <3 mo (n=428) 3 to <6 mo (n=653) 6 to <9 mo (n=651) 9+ mo (n=1040) P value
Maternal age at birth of index child, mean (SD), y 28.2 (4.6) 28.7 (4.7) 28.7 (4.3) 29.7 (4.2) 30.1 (4.0) 31.3 (4.1) <0.001
Race, n (%)
White 496 (97.5) 308 (97.2) 418 629 (96.3) 626 (96.2) 1008 (96.9) 0.233
Black <5 <5 (97.7) 5 (0.8) 9 (1.4) 8 (0.8)
Other <5 5 (1.6) <5 10 (1.5) 7 (1.1) 17 (1.6)
Missing 6 (1.2) <5 <57 (1.6) 9 (1.4) 9 (1.4) 7 (0.7)
Married, n (%)
No 89 (17.5) 44 (13.9) 62 (14.5) 115 (17.6) 73 (11.2) 147 (14.1) 0.034
Yes 415 (81.5) 271 (85.5) 363 (84.8) 537 (82.2) 572 (87.9) 882 (84.8)
Missing 5 (1.0) <5 <5 <5 6 (0.9) 11 (1.1)
Manual social class, n (%)
No 337 (66.2) 232 (73.2) 313 (73.1) 484 (74.1) 529 (81.3) 774 (74.4) 0.001
Yes 120 (23.6) 50 (15.8) 75 (17.5) 99 (15.2) 67 (10.3) 147 (14.1)
Missing 52 (10.2) 35 (11.0) 40 (9.4) 70 (10.7) 55 (8.5) 119 (11.4)
University‐level education, n (%)
No 485 (95.3) 292 (92.1) 376 (87.9) 542 (83.0) 464 (71.3) 698 (67.1) 0.001
Yes 18 (3.5) 20 (6.3) 46 (10.8) 106 (16.2) 182 (28.0) 335 (32.2)
Missing 6 (1.2) 5 (1.6) 6 (1.4) 5 (0.8) 5 (0.8) 7 (0.7)
Prepregnancy BMI, mean (SD), kg/m2 23.3 (4.0) 22.8 (3.6) 22.8 (3.6) 22.4 (3.3) 22.1 (2.9) 22.0 (2.9) <0.001
Primigravid, n (%)
No 348 (68.4) 179 (56.5) 258 (60.3) 378 (57.9) 395 (60.7) 734 (70.6) <0.001
Yes 158 (31.0) 137 (43.22) 166 (38.8) 267 (41.0) 253 (38.9) 300 (28.9)
Missing <5 <5 <5 8 (1.2) <5 6 (0.6)
Smoking at recruitment, n (%)
No 386 (75.8) 262 (82.7) 346 (80.8) 542 (83.0) 585 (89.9) 934 (89.8) <0.001
Yes 121 (23.8) 54 (17.0) 78 (18.2) 103 (15.8) 61 (9.4) 93 (8.9)
Missing <5 <5 <5 8 (1.2) 5 (0.8) 13 (1.3)
Pregnancy diabetes, n (%)
None 486 (95.5) 303 (95.6) 411 (96.0) 626 (95.9) 630 (96.8) 1004 (96.5) 0.904
GD 5 (1.0) <5 <5 <5 <5 5 (0.5)
Pre‐GD <5 <5 <5 <5 <5 <5
Glycosuria 16 (3.1) 11 (3.47) 12 (2.8) 23 (3.5) 18 (2.8) 27 (2.6)
HDP, n (%)
None 416 (81.7) 270 (85.2) 350 (81.8) 569 (87.1) 551 (84.6) 913 (87.8) 0.001
Gestational hypertension 79 (15.5) 42 (13.3) 60 (14.0) 74 (11.3) 87 (13.4) 114 (11.0)
Preeclampsia 14 (2.7) 5 (1.58) 18 (4.2) 10 (1.5) 13 (2.0) 13 (1.3)
Preterm birth, n (%)
No 486 (95.5) 296 (93.4) 415 (97.0) 629 (96.3) 621 (95.4) 1007 (96.8) 0.169
Yes 23 (4.5) 21 (6.6) 13 (3.0) 24 (3.7) 30 (4.6) 33 (3.2)
Follow‐up measures
Maternal age, mean (SD), y 46.6 (4.5) 46.9 (4.5) 47.1 (4.2) 48.0 (4.2) 48.4 (4.0) 49.6 (4.1) <0.001
Medication usage, n (%)
Antihypertensives 38 (7.47) 14 (4.42) 20 (4.67) 29 (4.44) 23 (3.53) 46 (4.42)
Cholesterol‐lowering agents 10 (1.96) <5 6 (1.40) 11 (1.68) 11 (1.69) 12 (1.15)
Diabetes medications 10 (1.96) <5 5 (1.17) <5 6 (0.92) 12 (1.15)

Categories with cell counts with <5 participants are designated as N<5 per Avon Longitudinal Study of Parents and Children policy to protect participant anonymity. BMI indicates body mass index; GD, gestational diabetes; and HDP, hypertensive disorders of pregnancy.